Six years after a B-cell ALL diagnosis at 21, William Yank shares how his view of therapy changed and why he is still working on his mental health.
|Articles|December 27, 2021
We Received the 2021 Great Non-Profits Top-Rated Award!
Thanks to you, NCAN has once again been awarded top rated nonprofit organization status.
Advertisement
Thanks to you, NCAN has once again been awarded top rated nonprofit organization status. It’s an award bestowed upon us by the community, and we’re proud to say that we’ve been honored with this award every year since 2011. This status helps bring even more credibility to our organization, which in turn helps donors and volunteers feel more confident in their choice to support us.
Advertisement
Related to this article
A Phoenix man with metastatic castration-sensitive prostate cancer shares how back pain led to a PSA test and how his family helped him cope.
Five CURE bloggers living with breast cancer share what Breast Cancer Awareness Month can miss, from metastatic disease to men and mammogram limits.
A study of 39,184 people with solid tumors, published Oct. 8, 2026, found that about 1 in 6 had an inherited genetic change that increased their cancer risk. Testing only people under 50 would have missed 72% of those with these changes.
Updated NCCN guidelines for mantle cell lymphoma favor BTK inhibitor pills in first treatment and say people with no detectable lymphoma after treatment can skip a stem cell transplant.
From a personalized melanoma vaccine to new options for biliary, stomach, lung and endometrial cancers, here are 5 ESMO 2026 abstracts to watch.
In the phase 2 CO.28 trial, all 4 patients with tumor DNA in their blood after chemotherapy were recommended surgery, versus 38.1% of those without it.
California Gov. Gavin Newsom signed AB 1682 on Sept. 27, requiring large-group health plans to cover prescribed scalp cooling starting Jan. 1, 2027. Medi-Cal coverage is pending federal approval.
Advertisement
Advertisement
Trending on CURE
1
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis
2
ESMO 2026 Preview: 5 Late-Breaking Trials Patients Should Watch
3
What Breast Cancer Awareness Month Leaves Out
4
FDA Withdraws Zepzelca Approval for Previously Treated Small Cell Lung Cancer
5